Brief: CytoTools Submission Of European Clinical Trials For Dermapro Imminent

bioXXmed AG

30/11/2017 09:38

Nov 30 (Reuters) - CYTOTOOLS AG  T5OG.DE : 
    * SUBMISSION OF EUROPEAN CLINICAL TRIALS FOR WOUND HEALING 
ACTIVE 
SUBSTANCE DERMAPRO(R) IMMINENT 
    * NEW AMERICAN INVESTOR, YORKVILLE ADVISORS GLOBAL, LP, 
PROVIDES 
A LONG-TERM FINANCING COMMITMENT 
    * EUROPEAN CLINICAL TRIALS FOR WOUND HEALING SUBSTANCE 
DERMAPRO 
WILL START IN COMING WEEKS 
 
Source text for Eikon:  ID:nEQcc4tfFa  
Further company coverage:  T5OG.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 722 0920;))